Bausch Health Cos Net Acquisitions/Divestitures 2010-2025 | BHC
Bausch Health Cos net acquisitions/divestitures from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
Bausch Health Cos Annual Net Acquisitions/Divestitures
(Millions of US $) |
| 2024 |
$7 |
| 2023 |
$5 |
| 2022 |
$-40 |
| 2021 |
$N/A |
| 2020 |
$N/A |
| 2019 |
$-180 |
| 2018 |
$5 |
| 2017 |
$N/A |
| 2016 |
$-19 |
| 2015 |
$-15,458 |
| 2014 |
$-1,102 |
| 2013 |
$-5,254 |
| 2012 |
$-3,485 |
| 2011 |
$-2,464 |
| 2010 |
$309 |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.695B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
